Abstract 23

Background 24
The last decade has witnessed dramatic improvements in whole-genome sequencing capabilities coupled 25 to drastically decreased costs, leading to an inundation of high-quality de novo genomes. For this reason, 26 continued development of genome quality metrics is imperative. The current study utilized the recently 27 updated Atlantic bottlenose dolphin (Tursiops truncatus) genome and annotation to evaluate a 28 proteomics-based metric of genome accuracy. 29
30
Results
31
Proteomic analysis of six tissues provided experimental confirmation of 10 402 proteins from 4 711 32 protein groups, almost 1/3 of the possible predicted proteins in the genome. There was an increased 33 median molecular weight and number of identified peptides per protein using the current T. truncatus 34 annotation versus the previous annotation. Identification of larger proteins with more identified peptides 35 implied reduced database fragmentation and improved gene annotation accuracy. A metric is proposed, 36 NP 10 , that attempts to capture this quality improvement. When using the new T. truncatus genome there 37 was a 21 % improvement in NP 10 . This metric was further demonstrated by using a publicly available 38 proteomic data set to compare human genome annotations from 2004, 2013 and 2016 , which had a 33 % 39 improvement in NP 10 . 40
41
Conclusions 42 These results demonstrate that new whole-genome sequencing techniques can rapidly generate high 43 quality de novo genome assemblies and emphasizes the speed of advancing bioanalytical measurements 44 in a non-model organism. Moreover, proteomics may be a useful metrological tool to benchmark genome 45 accuracy, though there is a need for reference proteomic datasets to facilitate this utility in new de novo 46 and existing genomes.
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Background 48
Since 2007 there has been a rapid decrease in whole-genome sequencing costs coupled with 49 improved read lengths and development of long-range techniques such as synthetic long-reads and 50 mapping protocols. Concurrently, the access to high performance computing environments has improved 51 along with an endless supply of new genome assembly and annotation tools. With these new resources it 52 is now possible to rapidly generate high-quality de novo genomes for non-model organisms. The second goal of the current study was to evaluate the new T. truncatus de novo genome assembly 125 (GCA_001922835.1) and annotation (NIST_Tur_tru v1). This genome assembly was generated in the fall 126 of 2016 using shotgun sequencing coupled to an in vitro histone ligation-based sequencing method (i.e., 127
Chicago method) and proprietary assemblers described in detail by Putnam et al. [6] . This process 128 resulted in a genome assembly with a scaffold N50 of 26.6 coding genes with 38 849 coding sequences. At the gene and transcript level, there were many changes 139 from Ttru_1.4 that are delineated based on alignment of genes and transcripts: identical, minor changes, 140 major changes, new, deprecated and other. These categories are defined and available through NCBI's 141 annotation report [19] . Briefly, 28 % of the prior genes and transcripts in Ttru_1.4 were deprecated, 72 % 142 had minor or major changes, and 21 % of the genes and transcripts in the NIST release are new. 143
Additionally, a small group of proteins have the prefix YP, which is not included in these NCBI 144
categories. 145
Tandem mass spectrometry data collected from all six tissues was searched against each release. 146
For both releases, almost 1/3 of the predicted protein-coding sequences were inferred by mass 147 spectrometry. Specifically the NIST assembly identified 32 582 peptide groups belonging to 10 402 148 proteins comprising 4 711 protein groups. The Ttru_1.4 assembly identified 33 738 peptide groups 149 belonging to 6 899 proteins comprising 5 292 protein groups. Many of the differences between the twoPage 7 results were due to a loss of deprecated sequences and minor/major changes ( Figure 2 ). Broadly, these 151 changes resulted in larger proteins with an increased median molecular weight and NP 10 molecular 152
weight. 153 154
Confirming improvements in gene annotation 155
There were 4,695 protein-coding sequences in the Ttru_1.4 annotation listed as partial, and one of the 156 main improvements in the new NIST annotation was that 86 % of these sequences were merged into 157 complete sequences. This offered an opportunity to evaluate the accuracy of these new assignments by 158 determining whether peptides identified by mass spectrometry supported the new complete sequences. Of 159 6 899 identified proteins using Ttru_1.4, 1 249 were partials. Of these 1 249 partial proteins identified 160 using Ttru_1.4, 534 had minor changes, 256 major, 450 were deprecated and 9 were other (defined simply 161 as other changes [19] ). When this NIST annotation was used, 1 005 of these same 1 249 proteins were 162 identified, with 985 no longer being listed as partial. The median improvement within each protein was 163 two additional unique peptides and overall the median molecular weight improved 1.8-fold ( Figure 3 ). Of 164 these 1 005 partial proteins identified using Ttru_1.4, when using the NIST annotation, 886 had increased 165 molecular weight and increased number of unique peptides. 166 167
Comparing peptide identifications 168
An unexpected result in the new annotation was that there were fewer peptide identifications. Given the 169 major changes between the two releases related to deprecated genes, new genes, and major changes, we 170 were interested in tracking these peptide level changes. Over 80 % of the peptide groups identified in 171 NIST annotation were also identified using the Ttru_1.4 annotation (Figure 4) . The new peptide 172 identifications were linked to major and minor changes in genes with only 3.2 % due to new sequences. 173
As would be expected, many of the peptide groups not identified in the NIST annotation were deprecated 174 (41 %). Given that these 5 657 peptide groups lost using the NIST annotation were high-confidencePage 8 identifications, it may provide evidence for re-inclusion of these protein-coding sequences in future 176 annotation releases. 177
178
Specific examples of annotation improvements 179
The goal of evaluating differences at a broad level is to capture and describe relevant changes at the 180 granular level. At the peptide level, one the most striking improvements was related to titin, a major 181 component in muscle tissue. In Ttru_1.4, titin (XP_004322250.1) was a partial sequence of 2,167 amino 182 acids (241.7 kDa) and 60 unique peptides (40.2 %) were identified belonging to this sequence. In the 183 NIST annotation, the coding sequence for titin (XP_019787158.1) was 32 192 amino acids (3 812.8 kDa) 184 and 779 unique peptides (34.3 % coverage) were identified belonging to this sequence. This single 185 sequence improvement is responsible for many changes observed at the peptide level (Figure 4) . 186
Almost 2 % of the identified proteins using the NIST annotation were considered new. One 187 important new protein of note is cystatin C (XP_019783122.1). This protein was not present in Ttru_1.4, 188 while using the NIST annotation the mass spectrometry data identified three unique peptides (41.3 % 189 coverage) belonging to the predicted 13.1 kDa protein. This protein has applications as a biomarker [20] , 190 and with these proteomic results, it is possible to create SI traceable mass spectrometer-based assays 191 (similar to [21] ). Another protein of note is serotransferrin (XP_019789750.1), which is 90 % identical 192 and 3.5 % longer than the entry in Ttru_1.4 annotation (XP_004329553.1). Most of these changes were 193 on the c-terminus section (from positions 537 to 634), which was supported by the proteomic data that 194 identified four peptides spanning this region. There were other slight changes to the sequence that resulted 195 in six more unique peptides identified in the improved serotransferrin, which supports the accuracy of the 196 new annotation. Overall, there are many changes related to the over 10 000 protein identifications and 197 many would be considered improvements as indicated by increased protein molecular weight and/or 198 greater peptide coverage. At a gene-by-gene level these results can be used to confirm and improve 199
annotations. 200
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Confirming quality metric in human annotations 202
In order to gauge the broader applicability of using proteomics as a quality measure of genomic 203 annotations, we demonstrated NP 10 The results of the current study provide empirical confirmation of protein annotations, including 232 observable proteotypic peptides, which can be a resource for future targeted studies in T. truncatus. For 233 example, by improving the protein-coding sequence accuracy of serotransferrin in T. truncatus, future 234 studies can extrapolate metrological advances in human serotransferrin sialoforms [25] to T. truncatus 235 disease treatment [26] . Since the current results are not an exhaustive proteomic dataset, future studies 236 will utilize different solubilization techniques, proteases, and separation techniques to provide even 237 deeper proteome coverage (reviewed and demonstrated in the following [13, 27, 28] ). Still, it is worth 238 noting that in single study using a simple experimental approach we have identified almost 1/3 of the 239 possible predicted proteins, emphasizing the ease of accomplishing bioanalytical advances in non-model 240 organisms using modern techniques. 241
In the current study, benchmark proteomic datasets were used to evaluate genome assembly and 242 annotation improvements in T. truncatus and H. sapiens. Typically, a reference database is used to 243 demonstrate proteomic improvements due to optimized protein extraction, solubilization and digestion, 244 peptide separation, mass spectrometer speed and mass accuracy, search algorithm performance andPage 11 database accuracy. In contrast, when the mass spectrometric data are held constant and instead the 246 database is varied, differences in proteomic results are indicative of database fragmentation and accuracy. 247
Proteomic analysis of multiple tissues allowed for greater protein diversity when evaluating T. truncatus, 248 though the publicly available human data performed exceptionally well despite using a single tissue since 249 it utilized highly optimized separation techniques. An optimum proteomic benchmark dataset would be 250 one that offers the possibility of the deepest proteome coverage. This would rely on using multiple 251 tissues, extraction protocols, enzymes and optimum separation techniques coupled to modern mass 252 spectrometers. These datasets could be developed in parallel to the exponential increase in de novo 253 genomes being released and annotated and would prove invaluable in exercises assessing assembly and 254
annotation performance (such as Assemblathon 2 [5]). Importantly, given the abundance and accessibility 255 of public proteomic data in this "Golden Age of Proteomics" (as coined by [29] ) and modular open-access 256 proteogenomic pipelines such as Galaxy-P [30, 31] , it would be possible to incorporate these reference 257 mass spectrometric datasets and proteomic derived quality metrics into genome assembly and annotation 258
pipelines. 259
In parallel to improvements in genome assembly contiguity and annotation accuracy, proteomic 260 results should have increased peptide numbers per protein, higher protein identifications due to isoform 261 resolution and improved coverage of higher molecular weight proteins due to better long-range accuracy. 262
For instance, when evaluating the substantial reduction in partial sequences between Ttru_1.4 and 263 NIST_Tur_tru v1, there was an increase of 81 % in median molecular weight of these proteins that 264 coincided with more peptide identifications within these new complete sequences. The most drastic 265 example in this case study was titin, which went from 60 to 779 identified peptides with the addition of 266 over 32 000 amino acids to the previously partial sequence. This also emphasizes that greater numbers of 267 protein identifications does not imply higher quality since a more fragmented genome will give more 268 protein identifications. Instead, identification of larger proteins with more identified peptides is more 269
indicative of improved quality. The proposed metric, NP 10 , attempts to capture this quality measure. One 270 issue is that the NP 10 may be glossing over how changes in spectral assignments to peptides withPage 12 changing databases affect proteomic quality (such as false discovery rates). There is an opportunity to 272 develop a streamlined method to track MS/MS spectra assignments and quantify those changes with 273 database improvements in order to establish finer measures of search space effects on proteomic 274 performance. Overall, these results demonstrate that new whole-genome sequencing techniques can 275 provide high quality de novo genome assemblies and that proteomics is a useful metrological tool to 276 evaluate annotation and benchmark genome accuracy. 277 278
Methods 279
Sample source and preparation 280
Bottlenose dolphin tissues were collected from animals under appropriate permits (Additional File Table  281 S1) and stored at liquid nitrogen temperatures (-150 to -180 °C) Samples were processed using Pierce C18 spin columns (8 mg of C18 resin; Thermo Scientific) according 298 to manufacturer's instructions. Each sample was processed in duplicate yielding at maximum of 60 µg 299 peptides. These solutions were evaporated to dryness in a vacufuge then reconstituted in 150 µL of 5 % 300 acetonitrile in water. 301
302
Mass Spectrometry 303
Samples were analyzed using an UltiMate 3000 Nano LC coupled to a Fusion Lumos mass spectrometer 304 acid] over 105 min followed by a ramp to 40 % mobile phase B over 15 min and lastly to 95 % mobile 310 phase B over 10 min at a flow rate of 300 nL/min. The mass spectrometer was operated in positive 311 polarity and data dependent mode (topN, 3 s cycle time) with a dynamic exclusion of 60 s (with 10 ppm 312 error). The RF lens was set at 30 %. Full scan resolution using the orbitrap was set at 120 000 and the 313 mass range was set to m/z 375 to1500. Full scan ion target value was 4.0e5 allowing a maximum injection 314 time of 50 ms. Monoisotopic peak determination was used, specifying peptides and an intensity threshold 315 of 1.0e4 was used for precursor selection. Data-dependent fragmentation was performed using higher-316 energy collisional dissociation (HCD) at a normalized collision energy of 32 with quadrupole isolation at 317 m/z 0.7 width. The fragment scan resolution using the orbitrap was set at 30 000, m/z 110 as the first 318 mass, ion target value of 2.0e5 and a 60 ms maximum injection time. has improved, there is a shift upward and to the right indicating annotations are more accurate (increased 473 coverage) and complete (increased molecular weight). The NP 10 improved 33 % and is indicated by the 474 red dotted line (note: these axes have been truncated for illustration and do not show all data points). 475
